Oscillometry helps assess treatment responsiveness in adults with asthma exacerbations

Respir Physiol Neurobiol. 2023 Jul:313:104065. doi: 10.1016/j.resp.2023.104065. Epub 2023 Apr 26.

Abstract

Background: It is necessary to evaluate the severity of asthma exacerbations for subjective symptoms and objective indicators. When patients cannot perform spirometry, oscillometry is a surrogate test.

Objective: We assessed the usefulness of oscillometry for the evaluation of treatment responsiveness in patients with asthma exacerbations.

Methods: The subjects included 21 consecutive patients with asthma exacerbations. Symptomatic responses, oscillometry, and spirometry (if possible) were assessed before and after treatment with corticosteroids and aminophylline.

Results: After treatment, all of the patients were allowed to return home and had no hospital visits. Oscillometry was feasible in all patients; however, spirometry could not be performed in 9 patients. Overall, there was a significant improvement in wheezing scores and oscillometric parameters, but not in FEV1 after treatment. The thresholds for a positive bronchodilator response in oscillometry were observed in 4 or more patients, while the minimal clinically important differences in FEV1 were observed in one patient.

Conclusion: Oscillometry can detect improvements that cannot.

Keywords: Asthma; Exacerbations; Oscillometry; Spirometry.

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Asthma* / diagnosis
  • Asthma* / drug therapy
  • Bronchodilator Agents / therapeutic use
  • Forced Expiratory Volume
  • Humans
  • Oscillometry
  • Spirometry

Substances

  • Bronchodilator Agents
  • Adrenal Cortex Hormones